On the 2nd of January 2015, the Azienda Ospedaliera di Padova (AOSP) has enrolled its first patient in the DEEP-2 study (multicentre, randomized, open label, controlled trial aimed at comparing the efficacy of deferiprone and deferasirox in paediatric patients). Other two paediatric patients have been included in […]
The DEEP project has received research funding from the European Union under the 7th Framework Programme
